The Long Island University Reopening Plan

  Return to Faculty Profiles


Agnes Cha

Associate Professor of Pharmacy Practice, Full-time

PharmD, University of Illinois at Chicago


Dr. Agnes Cha graduated summa cum laude from the University of Illinois College of Pharmacy in Chicago, IL.  After being born and raised in Chicago, she transplanted to NYC to pursue her interest in HIV/AIDS and ambulatory care.  She completed a Post Graduate Year-1 Pharmacy Practice Residency at the Veterans Affairs Hospital in Manhattan, NY and a Post Graduate Year-2 Ambulatory Care Residency with a focus on HIV Primary Care at the Brooklyn Hospital Center.  Dr. Cha has obtained certification as an HIV Pharmacist by the American Academy of HIV Medicine and is also a Board Certified Ambulatory Care Pharmacist.  

Dr. Cha is currently an Associate Professor of Pharmacy Practice at LIU College of Pharmacy and has been practicing as an HIV clinical pharmacist at a HIV Primary Care clinic affiliated with the Brooklyn Hospital Center.  She has implemented an interdisciplinary practice model and advocates for pharmacist involvement on the medical team.  She has also initiated a Hepatitis C clinic and manages co-infected patients.  Her passion centers on caring for HIV positive patients, both treatment naïve and experienced, and their co-morbidities as pharmacotherapy management becomes more complex. 

Dr. Cha serves as a preceptor for the Brooklyn Hospital Center's pharmacy residency program, for PGY1, PGY2-ID, and PGY-2 ambcare residents where she is a primary investigator for several research projects.  Dr. Cha also serves as a Director-At-Large for the Royal Counties chapter of New York State Council of Health-Systems Pharmacists (NYSCHP).  She also has opportunities to take students to resource poor countries through the International Pharmacy Practice & Public Health elective rotations. 


Research interests center on the management of HIV and comorbidities including Hepatitis C. Additional interests include evaluation of interdisciplinary practice models towards patient care and global health experiences to enrich student learning.


Billedo J, Berkowitz L, Cha A, “Evaluating the Impact of a Pharmacist-Led Antiretroviral Stewardship Program on Reducing Drug Interactions in HIV-Infected Patients.” J Int Assoc Provid AIDS Care. 2015; Aug 19; e-Pub ahead of print. (Senior author)

Cope R, Berkowitz L, Arcebido R, Yeh JY, Trustman N, Cha A, “Evaluating the effects on an interdisciplinary practice model with pharmacist collaboration on HIV patient co-morbidities.” AIDS Patient Care STDS.  2015; Aug; 29(8):445-53.  (Senior author)

Bias TE, Venugopalan V, Berkowitz LB, Cha A, “Incidence of antiretroviral drug interactions during hospital course: The role of a pharmacist-led antiretroviral stewardship.” J Pharm Technol. 2014; 30(2): 48-53.  (Senior author)

Cha A, Budovich A, “Sofosbuvir: A New Oral Once-Daily Agent for The Treatment of Hepatitis C Virus Infection.” Pharmacy & Therapeutics. 2014; 39(5): 345-352.

Vachirasudlekha B, Cha A, Berkowitz L, Shah B, “Interdisciplinary HIV care - Patient perceptions.” Int J Health Care Qual Assur. 2014; 27(5): 405-413.  (Senior author)

Cha A, Shaikh R, Williams S, Berkowitz L, “Rapid reduction of HIV viral load in late pregnancy with raltegravir: a case report.” J Int Assoc Provid AIDS Care. 2013; 12(5): 213-4.

Gatti D, Cha A, “Apparent interaction between telaprevir and warfarin in a patient with chronic hepatitis C viral infection.” Am J Health-Syst Pharm. 2012, 69:2062-65

Berrios-Colon E, Cha A.  The Treatment and Management of Atrial Fibrillation.  US Pharmacist.  2010, 35(2):26-38.

Other Publications

Cha A.  “Ask the HIV Specialist: Elevated (Liver) Concerns.”  Positively Aware.  May/June 2011; 41.


Cha, Agnes. “Chapter 37: HIV/AIDS” Primary Care, 2nd Edition: An Inter-professional Perspective. Ed. Joanne K. Singleton. New York: Springer Publishing Company, 2015. 555-585.

Lectures and Presentations

Sorbera M, Cha A, Del Bello D, Bichoupan K, Yalamanchili R, Harty A, Ng M, Stivala A, Gardenier D, Khaitova V, Salomon N, Mildvan D, Perlman D, Liu L, Odin J, Schiano T, Perumalswami P, Fierer D, Kotler D, Dieterich D, Branch A, “Evaluation of Sofosbuvir and Simeprevir Combination Therapy in an HCV/HIV Co-Infected Population”, 54th Annual Assembly: Taking it to the Top, Bolton Landing NY, 2015

Del Bello D, Bichoupan K, Levine C, Cha A, Perlman D, Salomon NH, Kotler D, Fierer DS, Dieterich DT, Branch AD, “Real-world Data on HIV-Positive Patients with HCV Treated with Sofosbuvir and/or Simeprevir”, Conference on Retroviruses and Opportunistic Infections (CROI), Seattle WA, 2015                                                                             

Elsamadisi P, Cha A, “Prevention of Perinatal Transmission in an HIV Infected Mother with Documented Resistance to Zidovudine and Nevirapine: A Case Report”, ASHP Midyear, Anaheim CA, 2014

Hammon K, Ocheretyaner E, Wong E, Cha A, “HIV: Embracing Medication Adherence & Smoking Cessation”, ASHP Midyear, Anaheim CA, 2014

Swamy S, Cha A, Yuseff J, Sharma R, Virologic Outcomes with Elvitegravir (EVG) and Raltegravir (RAL) in an Urban Cohort” And: “Statin Use in the ATP III Guidelines Compared to the 2013 ACC/AHA Guidelines in HIV Primary Care Patients”, ACCP Annual Meeting, Austin TX, 2014

Cope R, Cha A, Omoloju A, “Evaluation of budesonide use with interacting antiretroviral medications”, ASHP, Orlando FL, 2013

Cha A, Billedo JS, Berkowitz L , “Impact of clinical pharmacists’ intervention through an Antiretroviral Stewardship Program (ARVSP)”, Making a Difference in Infectious Diseases Pharmacotherapy (MAD-ID), Orlando FL, 2013

Arcebido A, Rubin R, Cha A, “Pharmacist interventions through collaborate drug therapy management in an interdisciplinary HIV clinic”, 52nd Annual Assembly: Medication Safety, Verona NY, 2012

Gim S, Cha A, “An international pharmacy practice and public health Advanced Pharmacy Practice Experience (APPE) in Port-au-Prince, Haiti”, ACCP, Kissimmee FL, 2012

Vachirasudlekha B, Berkowitz L, Cha A, “Treatment of acute hepatitis C with telaprevir, peginterferon alfa-2b, and ribavirin”, ASHP; New Orleans, LA, 2011

Cha A, Berrios-Colon E, Berkowitz L.  “Evaluating the management of diabetes mellitus type-2 in HIV-infected patients”, American Conference for Treatment of HIV; Denver CO, 2010


NYSCHP Research and Education Foundation Infectious Diseases Research Award  April 2015

NYSCHP Research and Education Foundation HIV Pharmacy Research Award   May 2014

Preceptor of the Year, Brooklyn Hospital Pharmacy Residency Program June 2011

Professional Affiliations

New York State Council of Health System Pharmacists (NYSCHP)  2009-Present
Royal Counties Chapter – Director at Large; 2014-present
Continuing Competency Committee; 2014-present                             
American Association of Colleges of Pharmacy (AACP)  2011-Present
American Academy of HIV Medicine (AAHIVM); Exam Writer 2010-Present
Physician’s Research Network (PRN)  2010-Present
American College of Clinical Pharmacy (ACCP) 2009-Present
American Society of Health System Pharmacists (ASHP) 2006-Present
Kappa Psi Pharmaceutical Fraternity  2004-Present
President; 2006-2007
Grand Council Deputy; 2015-Present


Cha, Agnes. “Chapter 37: HIV/AIDS” Primary Care, 2nd Edition: An Inter-professional Perspective. Ed. Joanne K. Singleton. New York: Springer Publishing Company, 2015. 555-585.